In a third-party trial with a commercial grower in Florida, the use of Thrivedo, according to its manufacturer Verano365, netted a 20:1 return on investment by producing a 31% increase in average bud yield.
Thrivedo features Verano365’s proprietary delivery technology, OpusMAX. In the trial, the product was utilized at 10 milliliters per gallon in eight treatments over the course of 12 weeks on cannabis sativa varietal ‘Gorilla Cookies’.
“In the Florida medicinal grower trial, we partnered with an operator that already had a top-notch fertilization program in place, and we wanted to see if we could take their yields to the next level,” says David Coorts, Technical Director for Verano365. “We saw not only increased bud yield, but also improved terpenes and other quality factors.”
The trial pitted the grower’s standard program against a program that added Thrivedo to the mix. Two benches of 17 plants each were harvested and sent to Kaycha Labs in Florida for analysis. The report showed the Thrivedo-treated plants gained 8.7% in terpenes, bumped up total THC by 8.8%, had a 6% boost in total CBD, and improved cannabinoids by 8.7% as compared to the control group.
OpusMAX creates supramolecular structures of the active ingredients in horticulture inputs, allowing for more localized delivery of nutrients to improve plant health.
Thrivedo is registered for use in all 50 states in the U.S. and is available to commercial medicinal cannabis growers.